Are you Dr. Kasubhai?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 40 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
844 N 5th Ave
Sequim, WA 98382Phone+1 360-683-9895Fax+1 360-582-5614
Summary
- Dr. Saifuddin Kasubhai, MD is an oncologist in Sequim, Washington. He is currently licensed to practice medicine in Washington, California, and Oregon. He is affiliated with PeaceHealth St. Joseph Medical Center and St. Anne Hospital.
Education & Training
- Jacobi Medical Center/Albert Einstein College of MedicineFellowship, Hematology and Medical Oncology, 1994 - 1996
- Lincoln Medical and Mental Health CenterResidency, Internal Medicine, 1991 - 1994
- Grant Medical CollegeClass of 1988
Certifications & Licensure
- WA State Medical License 2001 - 2027
- OR State Medical License 2019 - 2023
- AK State Medical License 2018 - 2022
- CA State Medical License 2020 - 2022
- HI State Medical License 2018 - 2022
- NY State Medical License 1998 - 2001
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification ARIA Medical Oncology EMR, Varian Medical Systems, 2013
Publications & Presentations
PubMed
- 14 citationsBiomarker Analyses from a Randomized, Placebo-Controlled, Phase IIIb Trial Comparing Bevacizumab with or without Erlotinib as Maintenance Therapy for the Treatment of ...Fairooz F. Kabbinavar, Louis Fehrenbacher, John D. Hainsworth, Saifuddin M. Kasubhai, Bruce Kressel
Journal of Thoracic Oncology. 2014-09-01 - 261 citationsA randomised, double-blind, placebo-controlled trial of trametinib, an oral MEK inhibitor, in combination with gemcitabine for patients with untreated metastatic adeno...Jeffrey R. Infante, Bradley G. Somer, Joon Oh Park, Chung-Pin Li, Max E. Scheulen
European Journal of Cancer. 2014-08-01 - 135 citationsATLAS: Randomized, Double-Blind, Placebo-Controlled, Phase IIIB Trial Comparing Bevacizumab Therapy With or Without Erlotinib, After Completion of Chemotherapy, With B...Bruce E. Johnson, Fairooz F. Kabbinavar, Louis Fehrenbacher, John D. Hainsworth, Saifuddin M. Kasubhai
Journal of Clinical Oncology. 2013-11-01